Sparassis crispa- Szmaciak gałęzisty, Siedzuń sosnowy a może Kozia broda oraz co spotkałem po drodze

W materiale znajdziecie informacje o siedzuniu sosnowym, czyli szmaciaku gałęzistym vel Koziej brodzie... Dodatkowo zobaczycie kilka kolejnych gatunków, które spotkałem po drodze.

PATRONITE: https://patronite.pl/slowziel
FACEBOOK:   / slowianskizielnik  
INSTAGRAM:   / slowianski_zielnik  

*Materiały, które warto przejrzeć:
1. Properties and Potential Applications of the Culinary-Medicinal Cauliflower Mushroom, Sparassis crispa Wulf.:Fr (Aphyllophoromycetideae): A Review. Gayathri Chandrasekaran, Deuk-Sil Oh, Hyun-Jae Shin. Int J Med Mushr. 2011;13(2):177-183.
2. IFN-gamma induction by SCG, 1,3-beta-D-glucan from Sparassi scrispa, in DBA/2 mice in vitro. Harada T et al. J Interferon Cytokine Res. 2002
Dec;22(12):1227-39.
3. New sesquiterpenoid from the mushroom Sparassis crispa. Kodani S et al. Biosci Biotechnol Biochem. 2009 Jan;73(1):228-9.
4. Novel phthalide compounds from Sparassis crispa (Hanabiratake),
Hanabiratakelide A-C, exhibiting anti-cancer related activity. Yoshikawa K,
Kokudo N, Hashimoto T, Yamamoto K, Inose T, Kimura T. Biol Pharm
Bull. 2010;33(8): 1355-9.
5. Natural products and biological activity of the pharmacologically active
cauliflower mushroom Sparassis crispa. Kimura T. Biomed Res Int. Epub
2013 Mar 18.
6. Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa.
Ohno N, Miura NN, Nakajima M, Yadomae T. Biol Pharm Bull. 2000
Jul;23(7):866-72.
7. Anti-angiogenic and anti-metastatic effects of beta-1,3-D-glucan purified from Hanabiratake, Sparassis crispa. Yamamoto K, Kimura T, Sugitachi A, Matsuura N. Biol Pharm Bull. 2009 Feb;32(2):259-63.
8. Induction of dendritic cell maturation by β-glucan isolated from Sparassis crispa. Kim HS. Int Immunopharmacol. 2010 Oct;10(10): 1284-94.
9. Oral Administration of Soluble β-Glucan Preparation from the Cauliflower Mushroom, Sparassis crispa (Higher Basidiomycetes) Modulated Cytokine Production in Mice. Hida TH et al. Int J Med Mushr. 2013;15(6):525-538
10. Sparassis crispa as biological response modifier. Hasegawa A et al. Gan To Kagaku Ryoho. 2004 Oct;31(11):1761-3.
11. Immunomodulating Activity of a b-Glucan Preparation, SCG, Extracted
from a Culinary–Medicinal Mushroom, Sparassis crispa Wulf.:Fr.
(Aphyllophoromycetideae), and Application to Cancer Patients. Ohno N et
al. Int J Med Mushr. 2003;5(4): 15. Two New Antifungal Metabolites
produced by Sparassis crispa in culture and in decayed trees. Woodward S, Sultan HY, Barrett DK, Pearce RB. J. Gen. Microbiol. 1993;139(1):153-159.
12. Effects of medicinal mushroom (Sparassis crispa) on wound healing in streptozotocin-induced diabetic rats. Kwon AH, Qiu Z, Hashimoto M,
Yamamoto K, Kimura T. Am J Surg. 2009 Apr;197(4):503-9.
13. Orally and topically administered Sparassis crispa (Hanabiratake) improved healing of skin wounds in mice with streptozotocin-induced diabetes. Yamamoto K, Kimura T. Biosci Biotechnol Biochem. 2013;77(6):1303-5.
14. Sparassis crispa (Hanabiratake) ameliorates skin conditions in rats and humans. Kimura T, Hashimoto M, Yamada M, Nishikawa Y. Biosci
Biotechnol Biochem. 2013;77(9):1961-3.
15. Sparassis crispa suppresses mast cell-mediated allergic inflammation: Role of calcium, mitogen-activated protein kinase and nuclear factor-κB. Kim HH, Lee S, Singh TS, Choi JK, Shin TY, Kim SH. Int J Mol Med. 2012
Aug;30(2):344-50.
16. Beneficial effect of Sparassis crispa on stroke through activation of
Akt/eNOS pathway in brain of SHRSP. Yoshitomi H, Iwaoka E, Kubo M,
Shibata M, Gao M. J Nat Med. 2011 Jan;65(1):135-41.